Concord Biotech #CONCORDBIO remains a high-quality fermentation API franchise experiencing a temporary earnings setback; the key upside lies in FY27 demand normalization, injectable ramp-up, new product launches, and CDMO scaling, while the main risks are geopolitical disruptions, execution in new businesses, and slower-than-expected conversion of growth initiatives.
POOR #Q4FY26 RESULT
JM Financial (#JMFINANCIL) is evolving from a credit-heavy NBFC into a diversified financial-services platform; the biggest upside comes from a recovery in capital markets and improved profitability in wealth management, while the biggest risk remains prolonged weakness in IPO and equity issuance activity.
POOR #Q4FY26 RESULT
Jupiter Wagons #JWL is transforming from a wagon manufacturer into a diversified rail-and-energy infrastructure company; the key upside comes from new railway orders, wheel-set manufacturing, and BESS growth, while the biggest risks are execution delays and dependence on railway tender activity.
POOR #Q4FY26 RESULT
Triveni Turbine Ltd (#TRITURBINE) today is gradually transforming from a cyclical sugar company into a combination of a sugar-ethanol platform plus a high-margin export-oriented industrial gearbox and defense company, with the PTB demerger acting as the key value-unlocking catalyst over the next 12–24 months. Execution risk persist
POOR #Q4FY26 RESULT
This is going to explode next , study and just get on board guys unlike data centers , entire AI value chain , defense, or even space , this domain is fresh about to breakout , huge multi decade potential. $ILMN $TWST $VEEV